That's a really important question, especially since monitoring the heart over time is a key part of managing wild-type ATTR amyloidosis — even when an echo looks clear right now.
General guidance suggests having repeat echocardiograms at least every 6 to 12 months. This helps track any changes in heart function over time Show Full Answer
That's a really important question, especially since monitoring the heart over time is a key part of managing wild-type ATTR amyloidosis — even when an echo looks clear right now.
General guidance suggests having repeat echocardiograms at least every 6 to 12 months. This helps track any changes in heart function over time, since wild-type ATTR primarily affects the heart. Here's why regular monitoring matters:
- An echo alone can't fully confirm or rule out cardiac amyloidosis in all cases
- Wild-type ATTR is a progressive condition, so changes can develop gradually
- Regular testing helps your care team catch any shifts early and adjust treatment if needed
It's worth having a direct conversation with your cardiologist about the right schedule for your specific situation. They may also recommend additional tests alongside the echo, such as a cardiac MRI or a PYP scan, depending on how things look over time.
Staying on top of regular check-ins gives the best chance of catching any changes before they become more serious.
July 13
Join
Your Privacy Choices
